Neocis

Neocis, established in 2009 and headquartered in the United States, is revolutionizing dental implant surgery through advanced robotics. The company's flagship product, Yomi, is the first and only FDA-cleared robotic device for dental surgery. Neocis collaborates closely with leading surgeons to comprehensively grasp their needs and treatment challenges, underscoring its commitment to pioneering innovative technologies and approaches, which in turn advance patient care and improve quality of life.

Neocis operates within the Health Care and Robotics industries and is accredited and A+ rated by the Better Business Bureau. The company raised a notable $20.00M Series D investment on 10 January 2024 from Mirae Asset Capital and nVentures. This demonstrates the recognition and support from key players in the investment landscape. As a pioneer in robotic-assisted surgery for dental procedures, Neocis is poised to make significant strides in transforming the field of dentistry and enhancing patient outcomes.